Drug & Supplement Interactions

Kava + Osimertinib Mesylate

Brand name of Osimertinib Mesylate

  • Tagrisso

Medically reviewed by

Also reviewed by the HelloPharmacist Editorial Team

Updated November 2026Details about this page

AI is used only to summarize verified clinical information, never the open internet. Our AI policy

The Bottom Line Moderate Interaction

It is unclear if kava inhibits P-glycoprotein (P-gp); research is conflicting. Of the 2 interaction records for this pair, the most serious is rated moderate.

This also applies to Tagrisso, a brand name of osimertinib mesylate.

Read the Full Interaction Report

Dr. Brian Staiger’s Quick Take

Kava might slow a pump that moves Tagrisso (osimertinib), letting more build up and possibly causing more diarrhea or mouth sores. Much of this is theoretical, but talk with your oncologist or pharmacist before adding kava, given its own liver injury risk.

Read his full note1-minute read
Moderate
Possible
2
DOthers: B

Ask a Question About This Combination

Ask in your own words about taking Kava with Osimertinib Mesylate. The answer comes from this page’s own records.

Try:

AI answers from this page’s interaction records and our own drug and supplement information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist. How we use AI

Interaction Report

Kava and Osimertinib Mesylate Interaction

2 interaction records apply to these two. Each one is explained separately below.

Why Are There 2 Interaction Records?

We file Kava’s interactions under single medicines and under categories of medicines that share an effect. Osimertinib Mesylate is named in, or belongs to, 2 of them, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We’ve listed each one below; the most serious of them (Moderate) sets the overall rating.

Moderate Interaction 1 of 2

Kava With P-glycoprotein Substrates

Why this applies to Osimertinib Mesylate

  1. The SupplementKava
  2. Interacts With the CategoryP-glycoprotein Substrates
  3. Which IncludesOsimertinib Mesylate

We sort drugs into categories. Osimertinib Mesylate is in our P-glycoprotein Substrates category, and Kava interacts with every drug in it, so this interaction applies to Osimertinib Mesylate.

Interaction Details Explained

It is unclear if kava inhibits P-glycoprotein (P-gp); research is conflicting.
In vitro research shows that kava can inhibit P-gp efflux. Additionally, animal research shows that kava can inhibit P-gp efflux, increasing the intestinal uptake of the P-gp substrate fexofenadine by 3.5-fold when compared with control. However, a clinical study in healthy volunteers shows that taking kava standardized to provide 225 mg kavalactones daily for 14 days does not affect the pharmacokinetics of digoxin, another P-gp substrate. It is possible that the use of other P-gp substrates or higher doses of kava might still inhibit P-gp.
Severity
ModerateUse caution: it may call for monitoring, timing changes or a dose change.
Likelihood
PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
Evidence
Grade DBased on lab or animal research, not studies in people.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Kava + P-glycoprotein Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the short version on combining kava with your Tagrisso (osimertinib). Osimertinib is moved around the body partly by a pump called P-glycoprotein (P-gp). In lab dishes, kava appears to slow that pump down, which in theory could let a bit more osimertinib build up. If that happened, you might notice more of the usual side effects, like diarrhea, mouth sores, dry or itchy skin, or nail changes.

The good news is that this is mostly theoretical. A human study found kava didn't change blood levels of digoxin, another P-gp drug, so a real-world effect is far from certain. Still, kava carries its own risk of liver injury, which matters during cancer treatment. Please loop in your oncologist or pharmacist before adding kava.

Still have a question about this interaction?

Contact Dr. Brian directly

References 4 sources behind this record

  1. Weiss J, Sauer A, Frank A, Unger M. Extracts and kavalactones of Piper methysticum G. Forst (kava-kava) inhibit P-glycoprotein in vitro. Drug Metab Dispos 2005;33:1580-3. PubMed
  2. Gurley BJ, Swain A, Barone GW, et al. Effect of goldenseal (Hydrastis canadensis) and kava kava (Piper methysticum) supplementation on digoxin pharmacokinetics in humans. Drug Metab Dispos 2007;35:240-5. PubMed
  3. Asher GN, Corbett AH, Hawke RL. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017;96(2):101-107.
  4. Nascimento ML, do Nascimento SB, Lima ESP, et al. Evaluation of the Effects of Extracts Containing Valeriana officinalis and Piper methysticum on the Activities of Cytochrome P450 3A and P-Glycoprotein. Planta Med 2024;90(10):792-800. PubMed
Minor Interaction 2 of 2

Kava With Cytochrome P450 3A4 (CYP3A4) Substrates

Osimertinib Mesylate is also in our Cytochrome P450 3A4 (CYP3A4) Substrates category.

Interaction Details Explained

It is unclear if kava inhibits CYP3AA; research is conflicting.
Although in vitro research suggests that kava inhibits CYP3A4, more robust clinical evidence shows that kava has no effect on CYP3A4. In a clinical study in healthy volunteers, taking kava 1000 mg twice daily (containing a daily dose of 138 mg kavalactones) for 28 days had no effect on CYP3A4 activity.
Severity
MinorLimited concern, but worth mentioning to your pharmacist.
Likelihood
UnlikelySeen in lab or animal research, but shown not to happen in people.
Evidence
Grade BBased on a smaller or less rigorous randomized trial, where people are assigned at random to the supplement or a comparison.

What every rating means

Dr. Brian Staiger, PharmD, BCPS
Explaining the Kava + Cytochrome P450 3A4 (CYP3A4) Substrates Interaction in Plain Words By Dr. Brian Staiger, PharmD, clinical pharmacist

Here's the short version on combining kava with Tagrisso (osimertinib). Your body clears osimertinib partly through a liver enzyme called CYP3A4. Early lab-dish studies hinted that kava might slow that enzyme down, which in theory could let osimertinib build up and raise the odds of side effects like diarrhea, rash, mouth sores, or fatigue. But here's the reassuring part: a better-quality human study found that kava at a real dose taken daily for a month had no measurable effect on CYP3A4. So this concern looks mostly theoretical.

The bigger issue I'd raise is that both kava and osimertinib can stress the liver, so stacking them isn't ideal. Please loop in your oncology pharmacist or doctor before adding kava.

Still have a question about this interaction?

Contact Dr. Brian directly

References 4 sources behind this record

  1. Mathews JM, Etheridge AS, Black SR. Inhibition of human cytochrome P450 activities by kava extract and kavalactones. Drug Metab Dispos 2002;30:1153-7. PubMed
  2. Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;1 PubMed
  3. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther 2005;77:415-26. PubMed
  4. Asher GN, Corbett AH, Hawke RL. Common Herbal Dietary Supplement-Drug Interactions. Am Fam Physician. 2017;96(2):101-107.
Know someone taking this combination? Share

Pharmacist Q&AYou ask. We answer.

Questions Our Pharmacists Have Answered About Kava and Osimertinib Mesylate

Real questions from readers, each answered by a licensed pharmacist at HelloPharmacist, written by a person and not generated from a database. An answer is written for the reader who asked and their situation, so read it for what to ask your own pharmacist rather than as a plan to follow.

Each one covers Kava or Osimertinib Mesylate, not necessarily both.

  1. The pharmacist says

    Red yeast rice can interact with Tagrisso because Tagrisso blocks an enzyme that breaks down red yeast rice, potentially causing it to build up in your blood. This interaction may increase the risk of muscle pain and weakness similar to side effects seen with statin medications. It's important to tell your doctor about all supplements you're taking, including red yeast rice, and report any muscle symptoms that develop.

    Answered by Dr. Brian Staiger, PharmD · February 2023
  2. The pharmacist says

    The Premier Fermented Mushroom Blend contains only minimal amounts of green tea caffeine, which is unlikely to cause problems when taking Tagrisso. None of the other ingredients in this supplement are known to have clinically significant interactions with Tagrisso. Always inform your doctor about all supplements you're taking so they can monitor you appropriately, since there is often limited data on natural product interactions.

    Answered by Dr. Brian Staiger, PharmD · January 2023

Your Whole Routine

Your Other Medicines and Supplements

Keep It in Perspective

Kava Also Interacts With Other Medications

Besides Osimertinib Mesylate, Kava has 248 major, 580 moderate, 338 minor known drug interactions in our database. If you take anything else, check it against the full list below.

Taking Anything Else?

Check Another of Your Medications Against Kava

Covers the 2,830 medications we’ve checked against Kava. Pick one to open its full report.

Everything Else You Take

See Every Supplement That Interacts With Osimertinib Mesylate

Take other supplements too? 169 supplements have a documented interaction with Osimertinib Mesylate, each explained on its page.

By severity: 8 major, 120 moderate and 41 minor.

The Most Serious There Right Now:

Open the Osimertinib Mesylate interaction pageEvery supplement checked against Osimertinib Mesylate, ranked by severity
One More Smart Check

Taking Kava as Part of a Dietary Supplement Product? Check It for Interactions

A product can hold more than Kava. We have broken down 403 supplement products that contain it, ingredient by ingredient. Find yours and we’ll check every ingredient against Osimertinib Mesylate:

Get to Know Each One

About Kava and Osimertinib Mesylate

Supplement

About Kava

Kava

Kava is a Pacific Island plant traditionally used to promote relaxation and ease anxiety, and some studies suggest it may help mild anxiety. However, kava has been linked to rare but serious liver damage, so it should be used with caution, avoided by people with liver problems, and only used after talking with your pharmacist or doctor.

Full Kava guide: uses, dosage, safety and every interaction
Medication

About Osimertinib

Brand name: Tagrisso

Osimertinib treats adults with non-small cell lung cancer (NSCLC) whose tumors have certain changes in the EGFR gene. An FDA-approved test is used to confirm the mutation.

Osimertinib: uses, dosage and side effects Osimertinib: interactions with other drugs Taking more than these two? Check Kava and Osimertinib with everything else you take Osimertinib NDC codes and packages

More to Explore

More Pairs and Interactions to Check

Similar Pairs

More Pairs Like Kava and Osimertinib Mesylate

Other drugs in the category this interaction applies to, and other supplements people check with Osimertinib Mesylate.

Moderate

Also in Our P-glycoprotein Substrates Category

Kava interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

185 more in this category are on the Kava interactions list.

Minor

Also in Our Cytochrome P450 3A4 (CYP3A4) Substrates Category

Kava interacts with every drug in this category, so each of these has the same interaction. The category is about a shared effect, not about being the same kind of medicine.

Show all 16 drugs in this categoryShow fewer

384 more in this category are on the Kava interactions list.

Other Supplements With Osimertinib Mesylate

The most serious documented interactions with Osimertinib Mesylate first, then supplements with none on record, the most looked-up leading.

Show all 25 supplementsShow fewer
Keep Checking

Other Drugs & Kava

Browse every other medication we’ve checked against Kava — both the ones with a known interaction and the ones without. Select any drug for the full detail.

248Major
580Moderate
338Minor
1,663No known interaction
Major

Major: 248 interactions

Showing 60 of 248 major interactions — see all 248 on the Kava page.

Moderate

Moderate: 580 interactions

Showing 60 of 580 moderate interactions — see all 580 on the Kava page.

Minor

Minor: 338 interactions

Showing 60 of 338 minor interactions — see all 338 on the Kava page.

No Interaction 1,663 drugs checked — show the list

We also checked Kava against these medications and found no known interaction in our sources. Open any page to confirm.

Showing 60 of the 1,663 medications checked with no known interaction, the most looked-up first — see the full Kava list.

How Much People Look This Up

Where Kava and Osimertinib Mesylate Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Kava
Top 10%

#105 of 1,458 supplements looked up here in the last 7 days

29 days ago today
Medication Osimertinib Mesylate
Steady interest

#1,440 of 2,830 medications looked up here in the last 7 days

29 days ago today

A rank of lookups on this site, not of how often either one is used. It counts every visit, automated ones included, and identifies no one.

Questions and Sources

Common Questions and Where This Comes From

Pharmacist Counseling Corner

Taking Kava and Osimertinib Mesylate Together: Common Questions

Can you take Kava with Osimertinib Mesylate?
There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Read the full details on this page and confirm with your pharmacist before combining them.
Can you take Kava with Tagrisso?
Tagrisso is a brand name of osimertinib mesylate, so the answer is the same as for osimertinib mesylate. There is a moderate interaction, so it may be acceptable with monitoring or timing changes. Everything on this page applies to Tagrisso too.
Why are there 2 interaction records for Kava and Osimertinib Mesylate?
We file interactions under single medicines and under categories of medicines that share an effect. Osimertinib Mesylate is named in, or belongs to, 2 of the categories we list for Kava, so 2 records apply. They can describe the same effect, so they are not 2 separate risks. We list every one so nothing is missed, and the most serious one sets the overall rating.
How serious is the Kava and Osimertinib Mesylate interaction?
We rate it Moderate. This combination may require monitoring, a dose adjustment, or separating the times you take each one. Consult your pharmacist before using them together.

Written and reviewed by the HelloPharmacist Editorial Team. Our editorial policy

Sources

Sources & How We Checked

Interaction details are evidence-graded and sourced from the Natural Medicines database. The medication overview comes from MedlinePlus.

Content is reviewed by the HelloPharmacist Editorial Team, the pharmacists on our staff and those we contract. See our data sources and editorial standards for how this information is built and checked.

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep Exploring
Rating Key

What Our Interaction Ratings Mean

Every interaction on this page is rated three ways: how serious it is, how likely it is to happen, and how strong the research behind it is.

See what each rating means

Severity: How Serious Is It?

How clinically significant the interaction is: how much it could affect your health or your treatment.

  • MajorClinically significant. Best to avoid the combination, or use only under close professional supervision.
  • ModerateBe cautious. The combination may call for monitoring, timing changes, or a dose adjustment.
  • MinorLimited clinical concern, but still worth being aware of and mentioning to your pharmacist.
  • No Known InteractionNo documented interaction in our sources.

Likelihood: How Likely Is It to Happen?

How strong the proof is that the interaction really happens in people. More filled steps, stronger proof.

  • LikelyShown in well-controlled studies in people.
  • ProbableShown in small studies in people, or in animal studies backed by case reports.
  • PossibleSeen in lab or animal research, or in people only in case reports or mixed results.
  • UnlikelySeen in lab or animal research, but shown not to happen in people.

Evidence: How Strong Is the Research?

The quality of the studies behind the rating, graded from A, the strongest, to D.

  • Grade AStrong: well-run randomized trials in people, or a review that pooled several of them.
  • Grade BFair: smaller or less rigorous trials in people, or studies that followed or compared groups of people.
  • Grade CLimited: the agreement or opinion of experts, not studies.
  • Grade DWeak: reports of single cases, lab or animal research, or what is expected from how the two work.

Still Have a Question About Kava and Osimertinib Mesylate?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.